CH539012A - Verfahren zur Herstellung neuer Phenoxyalkancarbonsäuren - Google Patents

Verfahren zur Herstellung neuer Phenoxyalkancarbonsäuren

Info

Publication number
CH539012A
CH539012A CH567770A CH567770A CH539012A CH 539012 A CH539012 A CH 539012A CH 567770 A CH567770 A CH 567770A CH 567770 A CH567770 A CH 567770A CH 539012 A CH539012 A CH 539012A
Authority
CH
Switzerland
Prior art keywords
new
production
phenoxyalkanecarboxylic acids
phenoxyalkanecarboxylic
acids
Prior art date
Application number
CH567770A
Other languages
German (de)
English (en)
Inventor
Nakamura Yasushi
Agatsuma Kunio
Tanaka Yoshihiro
Aono Shunji
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP2990769A external-priority patent/JPS5010299B1/ja
Priority claimed from JP2990569A external-priority patent/JPS5010298B1/ja
Priority claimed from JP8004269A external-priority patent/JPS5010308B1/ja
Priority claimed from JP10419469A external-priority patent/JPS4939995B1/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Priority claimed from US00206966A external-priority patent/US3821404A/en
Publication of CH539012A publication Critical patent/CH539012A/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/72—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/367—Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by introduction of functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/41—Preparation of salts of carboxylic acids
    • C07C51/412—Preparation of salts of carboxylic acids by conversion of the acids, their salts, esters or anhydrides with the same carboxylic acid part
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH567770A 1969-04-16 1970-04-16 Verfahren zur Herstellung neuer Phenoxyalkancarbonsäuren CH539012A (de)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
JP2990769A JPS5010299B1 (enExample) 1969-04-16 1969-04-16
JP2990569A JPS5010298B1 (enExample) 1969-04-16 1969-04-16
JP3416769 1969-05-02
JP3416669 1969-05-02
JP8004269A JPS5010308B1 (enExample) 1969-10-03 1969-10-03
JP8004169 1969-10-03
JP10280969 1969-12-19
JP10419469A JPS4939995B1 (enExample) 1969-12-23 1969-12-23
US2641270A 1970-04-07 1970-04-07
US00206966A US3821404A (en) 1969-04-16 1971-12-10 Phenoxy carboxylic acid derivatives as anti-atherosclerosis agents

Publications (1)

Publication Number Publication Date
CH539012A true CH539012A (de) 1973-08-31

Family

ID=27579824

Family Applications (2)

Application Number Title Priority Date Filing Date
CH567770A CH539012A (de) 1969-04-16 1970-04-16 Verfahren zur Herstellung neuer Phenoxyalkancarbonsäuren
CH748073A CH556807A (de) 1969-04-16 1970-04-16 Verfahren zur herstellung neuer phenoxyalkancarbonsaeuren und ester derselben.

Family Applications After (1)

Application Number Title Priority Date Filing Date
CH748073A CH556807A (de) 1969-04-16 1970-04-16 Verfahren zur herstellung neuer phenoxyalkancarbonsaeuren und ester derselben.

Country Status (9)

Country Link
US (2) US3716583A (enExample)
AT (2) AT302278B (enExample)
BE (1) BE748970A (enExample)
CA (1) CA964273A (enExample)
CH (2) CH539012A (enExample)
DK (1) DK128731B (enExample)
FI (1) FI52570C (enExample)
FR (1) FR2042333B1 (enExample)
NL (1) NL139016B (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4008265A (en) * 1971-05-22 1977-02-15 Sumitomo Chemical Company, Limited Novel bisphenoxy carboxylic acid derivatives and their salts
US4092324A (en) * 1971-05-22 1978-05-30 Sumitomo Chemical Company, Limited Diheterocyclic esters of 4-(1,1-bis-(phenoxy-propionic or -butoyric acid)-cyclohexane)α-methyl substituted
JPS575214B2 (enExample) * 1972-06-01 1982-01-29
JPS4931651A (enExample) * 1972-07-20 1974-03-22
JPS5735171B2 (enExample) * 1973-07-02 1982-07-27
AT353776B (de) * 1973-12-27 1979-12-10 Siegfried Ag Verfahren zur herstellung von neuen alkan- saeuren, deren estern und salzen
CH617417A5 (enExample) * 1973-12-27 1980-05-30 Siegfried Ag
FR2428629A1 (fr) * 1978-06-14 1980-01-11 Hexachimie Nouveaux composes bis(aryloxycarboxyliques), leur preparation et leur utilisation en therapeutique
EP0363760A1 (de) * 1988-10-12 1990-04-18 Bayer Ag Aromatische Ether
US5179097A (en) * 1991-06-10 1993-01-12 Angres Isaac A Salts of non-steroidal anti-inflammatory carboxylic acids and anti-lipidemic carboxylic acids
US6083497A (en) * 1997-11-05 2000-07-04 Geltex Pharmaceuticals, Inc. Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers
US6982251B2 (en) * 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
IL156445A0 (en) * 2001-01-26 2004-01-04 Schering Corp Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
EP1385548B1 (en) * 2001-01-26 2007-05-23 Schering Corporation Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
NZ542090A (en) * 2001-01-26 2006-09-29 Schering Corp Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions
KR20070120617A (ko) * 2001-01-26 2007-12-24 쉐링 코포레이션 치환된 아제티딘온 화합물을 포함하는 약제학적 조성물
US20060287254A1 (en) * 2001-01-26 2006-12-21 Schering Corporation Use of substituted azetidinone compounds for the treatment of sitosterolemia
US7071181B2 (en) * 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
TW200840563A (en) * 2001-01-26 2008-10-16 Schering Corp Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(S) and treatments for vascular indications
EP1911462A3 (en) 2001-01-26 2011-11-30 Schering Corporation Compositions comprising a sterol absorption inhibitor
PT1363668E (pt) * 2001-01-26 2007-11-07 Schering Corp Combinaçoes de sequestrante(s) de ácidos biliares e inibidor(es) de absorção de esterol e tratamento de indicações vasculares
WO2002096415A2 (en) * 2001-05-25 2002-12-05 Schering Corporation Use of azetidinone substituted derivatives in the treatment of alzheimer's disease
US7053080B2 (en) * 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
DE60229406D1 (de) * 2001-09-21 2008-11-27 Schering Corp Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en)
US20030119808A1 (en) * 2001-09-21 2003-06-26 Schering Corporation Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
US7056906B2 (en) * 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
EP1429756B1 (en) * 2001-09-21 2006-11-22 Schering Corporation Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
CA2504916A1 (en) * 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
US7459442B2 (en) * 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
WO2004081004A1 (en) * 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
WO2004081002A1 (en) * 2003-03-07 2004-09-23 Schering Corporation Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
DE602004018617D1 (de) * 2003-03-07 2009-02-05 Schering Corp Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
SG141430A1 (en) * 2003-05-30 2008-04-28 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
WO2005046797A2 (en) * 2003-11-05 2005-05-26 Schering Corporation Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
US6998397B2 (en) * 2004-07-23 2006-02-14 Drebsk Comptech, Inc. Method for decreasing cholesterol level in blood
BRPI0618379A2 (pt) * 2005-11-08 2011-08-30 Ranbaxy Lab Ltd processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
AU2007274724B2 (en) * 2006-07-14 2012-07-26 Ranbaxy Laboratories Limited Polymorphic forms of an HMG-CoA reductase inhibitor and uses thereof
TW200901959A (en) 2007-03-09 2009-01-16 Indigene Pharmaceuticals Inc Combination of metformin R-(+) lipoate and antihyperlipidemic agents for the treatment of diabetic hyperglycemia and diabetic complications
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
ES2905872T3 (es) 2015-02-06 2022-04-12 Intercept Pharmaceuticals Inc Composiciones farmacéuticas para terapia combinada
CN104610051A (zh) * 2015-03-02 2015-05-13 北京万全德众医药生物技术有限公司 一种制备克利贝特杂质的方法
US20220226350A1 (en) 2019-05-30 2022-07-21 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions comprising a fxr agonist and a fibrate for use in the treatment of cholestatic liver disease

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2444594A (en) * 1947-08-07 1948-07-06 American Cyanamid Co Isopropylidene-p-phenoxy-2-ethanol-p-phenoxyacetic acid
US2541003A (en) * 1948-08-17 1951-02-06 American Cyanamid Co Process for reacting salts of phenols with halo-alkanoic acid compounds
GB860303A (en) * 1958-06-20 1961-02-01 Ici Ltd Pharmaceutical compositions comprising ª‡-aryloxy-aliphatic carboxylic acids and/or ª
US3169144A (en) * 1960-08-12 1965-02-09 Massarani Elena Anticholesterinemic and antilipaemic agents
GB970969A (en) * 1963-08-15 1964-09-23 Shell Int Research Dicarboxylic acids and their esters and a process for the preparation thereof
FR1380816A (fr) * 1963-11-18 1964-12-04 Ciba Geigy Procédé de préparation de nouveaux acides isobutyriques, entre autres de l'acide alpha-[p-(2-p'-chlorophényl-propyl-[2])-phénoxy]-isobutyrique
US3470234A (en) * 1965-08-23 1969-09-30 Ciba Geigy Corp Diaryl substituted benzocycloalkanes
US3470235A (en) * 1965-11-05 1969-09-30 Eastman Kodak Co Alicyclic bisphenyleneoxydicarboxylic acids,salts and esters
GB1121722A (en) * 1966-03-31 1968-07-31 Ici Ltd New carboxylic acid derivatives
US3630715A (en) * 1968-12-19 1971-12-28 Weston Chemical Corp Alkylene bis (phenoxyacetic acid) derivatives as herbicides
US3755603A (en) * 1970-07-01 1973-08-28 Syntex Corp Biphenylyloxyacetic acids in pharmaceutical compositions

Also Published As

Publication number Publication date
US3959484A (en) 1976-05-25
FR2042333B1 (enExample) 1973-04-06
US3716583A (en) 1973-02-13
CA964273A (en) 1975-03-11
AT303015B (de) 1972-11-10
NL139016B (nl) 1973-06-15
AT302278B (de) 1972-10-10
FI52570B (enExample) 1977-06-30
NL7005400A (enExample) 1970-10-20
BE748970A (fr) 1970-09-16
CH556807A (de) 1974-12-13
FI52570C (fi) 1977-10-10
DK128731B (da) 1974-06-24
FR2042333A1 (enExample) 1971-02-12

Similar Documents

Publication Publication Date Title
CH531516A (de) Verfahren zur Herstellung neuer Phenylimidazolyl-fettsäure-derivate
AT311315B (de) Verfahren zur Herstellung neuer Alkoxydinitroaniline
AT302989B (de) Verfahren zur Herstellung von Bromnitroalkoholen
AT300371B (de) Verfahren zur Herstellung von Polyurethanen
CH536803A (de) Verfahren zur Herstellung neuer Naphthylpropionsäuren
CH536278A (de) Verfahren zur Herstellung neuer substituierter Salicylsäuren
CH508627A (de) Verfahren zur Herstellung neuer Hexahydrobenzazocine
CH537895A (de) Verfahren zur Herstellung neuer Hydroxycrotonsäuren
AT306256B (de) Verfahren zur Herstellung neuer Benzomorphanderivate
AT303272B (de) Verfahren zur Herstellung neuer Evomonosid-Derivate
CH535730A (de) Verfahren zur Herstellung neuer Naphthylalkanole
CH535596A (de) Verfahren zur Herstellung neuer modifizierter Säurekristalle
AT298489B (de) Verfahren zur Herstellung neuer 7-Nitro-8-hydroxy-chinolinester
CH540299A (de) Verfahren zur Herstellung neuer Phosphornitrilester
AT305266B (de) Verfahren zur Herstellung neuer substituierter 2-Benzylphenole
AT301504B (de) Verfahren zur Herstellung von Alkoholen
CH537390A (de) Verfahren zur Herstellung von Phenyl-pyrimidin-carbonsäuren
AT295512B (de) Verfahren zur Herstellung neuer Pyrrolderivate
AT319608B (de) Verfahren zur Herstellung neuer Polyepoxydpolysiloxane
CH498817A (de) Verfahren zur Herstellung neuer Isothiocyanato-diphenylamine
AT297021B (de) Verfahren zur Herstellung neuer Xanthinverbindungen
CH518973A (de) Verfahren zur Herstellung neuer Furanonderivate
CH509389A (de) Verfahren zur Herstellung von Phthalocyaninsulfonsäuren
CH528492A (de) Verfahren zur Herstellung neuer 18-Methyl-5a-H-androstane
CH529086A (de) Verfahren zur Herstellung neuer a-Phenylcarbonsäuren

Legal Events

Date Code Title Description
PL Patent ceased